A study to evaluate an oral medication, Siponimod (BAF312), in patients with Secondary Progressive Multiple Sclerosis

  • STATUS
    Recruiting
Send
Updated on 19 February 2024

Summary

The main purpose of the study is to see how effective and safe BAF312 is compared to a Placebo in patients with Secondary Progressive MS. A placebo is a “pill” (capsule or tablet) with no medicine inside. A placebo is used to make sure that the changes you report are just not happening by chance, ex. by comparing the results in patients taking BAF312 to those in patients taking placebo. By participating in this trial, you will either receive BAF312 or a Placebo.

Description

This study includes 3 parts: 1. A screening phase- to see if you are eligible to participate in this study, 2. A study drug/placebo treatment phase- this will include visits (which will occur every three months after the Day 1, Day 7 and Day 28 visits) that will monitor you throughout the study while taking the study drug or placebo, and 3. A follow-up phase, which will include safety assessments, but will not involve the administration of study drug or placebo.

Details
Condition Multiple sclerosis,Secondary Progressive
Age 18years - 60years
Clinical Study IdentifierTX258
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.